The survival impact of postoperative infection in patients with glioblastoma multiforme

Neurosurgery

Volumn 64, Issue 5, 2009, Pages 828-834

  Bohman, Leif Erik ^a,b   Gallardo, Jade ^a   Hankinson, Todd C ^a   Waziri, Allen E ^a   Mandigo, Christopher E ^a   McKhann, Guy M ^a   Sisti, Michael B ^a   Canoll, Peter ^a   Bruce, Jeffrey N ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bacterial infection; Glioblastoma; Glioblastoma multiforme; Glioma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; BACTERIAL INFECTION; BRAIN ABSCESS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CRANIOTOMY; DISEASE ASSOCIATION; FEMALE; GLIOBLASTOMA; GRAFT INFECTION; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; WOUND INFECTION; ARTICLE; BRAIN TUMOR; CLASSIFICATION; EVALUATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEUROSURGERY; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY;

ADULT; AGED; BACTERIAL INFECTIONS; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 67650727374     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000343525.89321.C5     Document Type: Conference Paper

References (16)

1. Bowles AP Jr, Perkins E: Long- term remission of malignant brain tumors after intracranial infection: A report of four cases. Neurosurgery 44:636-643, 1999.
2. Chicoine MR, Won EK, Zahner MC: Intratumoral injection of lipopolysaccha-ride causes regression of subcutaneously implanted mouse glioblastoma mul-tiforme. Neurosurgery 48:607-615, 2001.
3. Coley WB: The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases. 1893. Am J Med Sci 105:487-511, 1893.
4. Coley WB: The therapeutic value of the mixed toxins of the streptococcus of erysipelas and bacillus prodigiosus in the treatment of inoperable malignant tumors, with a report of one hundred and sixty cases. Am J Med Sci 112:251-281, 1896.
5. Harmer TW: A study of the efficiency of mixed toxins (Coley) in inoperable sarcoma. A critical analysis of 134 microscopically proven cases. Boston Med Surg J 172:331-338, 373-337, 411-336, 440-338, 1915.
6. Hoption Cann SA, van Netten JP, van Netten C: Dr William Coley and tumour regression: A place in history or in the future. Postgrad Med J 79:672-680, 2003.
7. Ide S: Fever and survival with drug- treated non- small cell lung cancer. Kurume Med J 48:9-14, 2001.
8. Kapp JP: Microorganisms as antineoplastic agents in CNS tumors. Arch Neurol 40:637-642, 1983.
9. Margolis J, West D: Spontaneous regression of malignant disease: report of three cases. J Am Geriatr Soc 15:251-253, 1967.
10. Miller JT, Rahimi SY, Lee M: History of infection control and its contributions to the development and success of brain tumor operations. Neurosurg Focus 18:e4, 2005.
11. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Isoe S, Nakano S, Nukui H: Long-term survival in a young patient with anaplastic glioma. Brain Tumor Pathol 14:71-74, 1997.
12. Nauts HC: Bacteria and cancer - Antagonisms and benefits. Cancer Surv 8:713-723, 1989.
13. Nauts HC, Fowler GA, Bogatko FH: A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; A critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand Suppl 276:1-103, 1953.
14. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH: Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:287-295, 1998.
15. Walker DG, Pamphlett R: Prolonged survival and pulmonary metastases after local cure of glioblastoma multiforme. J Clin Neurosci 6:67-68, 1999.
16. Won EK, Zahner MC, Grant EA, Gore P, Chicoine MR: Analysis of the anti-tumoral mechanisms of lipopolysaccharide against glioblastoma multiforme. Anticancer Drugs 14:457-466, 2003.